JUL 19, 2018 9:00 AM PDT

Investigating the role of microRNAs in pancreatic cancer progression

Speaker

Abstract
DATE:  July 19, 2018
TIME:  09:00am PDT
 

Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with a 5 year-survival rate of approximately 6%. Despite recent efforts in developing novel therapies, chemotherapy remains the standard of care for advance pancreatic cancer patients. MicroRNAs (miRNAs) are short non-coding RNAs that act as post-transcriptional negative regulators of gene expression. Our laboratory is interested in investigating how miRNAs dysregulation contribute to PDAC tumourigenesis. One of the major signalling pathways that drives tumourigenesis in PDAC is the TGF-β pathway. This pathway promotes epithelial-to-mesenchymal transition (EMT), metastasis and stemness. In this study we aimed to find out whether miRNAs were involved in the TGF-β response, as this was yet largely unknown. We used miRNA expression profiling and identified miRNAs regulated by TGF-β. We then focused on the top two miRNAs upregulated by TGF-β and characterized their role in PDAC. We used several strategies to inhibit the function of these miRNAs, including the genome editing approach CRISPR. With these systems we showed that silencing of these miRNAs impaired EMT, motility, stemness in vitro and tumourigenesis and metastasis in vivo. Furthermore, we identified globally the targets of these miRNAs by integrating AGO2-RIP sequencing with RNA-sequencing upon overexpression of the miRNA of interest. We found that the candidate miRNA targets significantly overlap and mainly inhibit p53 and cell to cell junctions’ pathways, which are all important in PDAC progression. We also showed that the candidate miRNAs were up-regulated in PDAC patient samples, and their specific tumoral expression strongly correlated with reduced overall survival and disease-free survival. These findings demonstrate a fundamental role of miRNAs within the TGF-β response and represent potential novel targets for therapeutic intervention in PDAC.

Learning Objectives:

  • Understand the role of miRNAs in pancreatic cancer
  • Learn how miRNAs affect tumourigenesis and metastasis using in vitro and in vivo models
  • Learn how we can efficiently identify miRNA functional targets using an experimental approach
 

Show Resources
JUL 19, 2018 9:00 AM PDT

Investigating the role of microRNAs in pancreatic cancer progression


Specialty

Cancer Research

Molecular Biology

Cell Biology

Biomarkers

Immunology

Biochemistry

Genetics

Biotechnology

Cancer Diagnostics

Cancer Therapeutics

Molecular Diagnostics

Gene Expression

Pcr/rt-Pcr/real-Time Pcr

Genomics

Oncology

Geography

North America56%

Europe22%

Asia13%

South America5%

Africa3%

Registration Source

Website Visitors50%

Email Promotions34%

WAVE Newsletter Promotion15%

Other2%

Job Title

Student16%

Medical Laboratory Technician14%

Research Scientist13%

Educator/Faculty10%

Executive8%

Scientist7%

Medical Doctor/Specialist7%

Clinical Laboratory Scientist6%

Facility/Department Manager6%

Post Doc5%

Lab Management4%

QC/QA2%

Consultant1%

Chemist1%

Organization

Academic Institution21%

Hospital13%

Clinical Laboratory11%

Research Institute10%

Biotech Company7%

Medical Center6%

Medical School5%

Government4%

Pharmaceutical Company2%

Consultant2%

Non-Profit Organization2%

Ambulatory Care2%

Life Science Company1%

Independent Laboratories1%

Other7%


Show Resources
Show Resources
Connect with us